Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excilor Forte vs Amorolfine in Toenail Onychomycosis
NCT03382717Completed
- Sponsor
- Oystershell
- Start
- Oct 2016
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Oystershell. Primary endpoint: Variation of the percentage of healthy surface at 180 days. Started Oct 2016; status: completed.
Beyond the preview
Go deeper on NCT03382717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03382717.